Merck & Co. Inc. said on Monday it has applied for U.S. emergency use authorization for its tablet to treat mild-to-moderate patients of COVID-19, putting it on course to become the first oral antiviral medication for the disease.
Coronavirus: What's happening in Canada and around the world on Monday
Post a Comment